PROM1 and neoplasm: Rutella et al. analyzed 113 tumor samples of EC and demonstrated that isolated CD133+ cells showed a more aggressive proliferation in vitro, a greater colony-forming ability and an higher resistance to cisplatin and paclitaxel compared with CD133− cells [63].